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Inspiratory fraction and exercise impairment
in COPD patients GOLD stages II–III
A.L.P. Albuquerque, L.E. Nery, D.S. Villac¸a, T.Y.S. Machado, C.C. Oliveira,
Aˆ.T. Paes and J.A. Neder
ABSTRACT: The inspiratory-to-total lung capacity ratio or ‘‘inspiratory fraction’’ (inspiratory
capacity(IC)/total lung capacity (TLC)) may be functionally more representative than traditional
indices of resting airflow limitation and lung hyperinflation in patients with chronic obstructive
pulmonary disease (COPD).
In the present retrospective study, a comparison was made of the individual performance of
post-bronchodilator IC, IC/TLC and forced expiratory volume in one second (FEV1) in predicting a
severely reduced peak oxygen uptake (V9O2; ,60% predicted) in 44 COPD patients Global
Initiative for Chronic Obstructive Lung Disease stages II-III (post-bronchodilator FEV1 ranging
from 31–79% pred).
Patients with lower IC/TLC values (f0.28) showed increased lung volumes and reduced
exercise capacity as compared with other subjects. Following a multiple linear regression
analysis, only IC/TLC and FEV1 remained as independent predictors of V9O2 (r
250.33). A receiver
operating characteristic (ROC) curve analysis revealed that an IC/TLC f0.28 had the highest
specificity (89.6%), positive predictive value (80%) and overall accuracy (86.3%) in identifying
patients with V9O2 ,60% pred. In addition, the area under the ROC curve tended to be higher for
IC/TLC than IC.
In conclusion, post-bronchodilator total lung capacity-corrected inspiratory fraction provides
useful information in addition to forced expiratory volume in one second and inspiratory capacity,
to estimate the likelihood of chronic obstructive pulmonary disease patients to present with
severely reduced maximal exercise capacity.
KEYWORDS: Chronic obstructive pulmonary disease, dyspnoea, exercise, inspiratory fraction,
lung hyperinflation, lung volumes
E
xercise intolerance is the hallmark of
chronic obstructive pulmonary disease
(COPD), being ascribed to complex inter-
actions between ventilatory, cardiovascular and
peripheral muscle abnormalities [1]. Amongst the
pulmonary-ventilatory mechanisms that could
contribute to exercise impairment in these
patients, dynamic hyperinflation (DH) seems to
be of special relevance [1, 2]. In this context,
inspiratory capacity (IC) at rest and during
exercise have been shown to be superior to
traditional measures of airflow obstruction (such
as forced expiratory volume in one second
(FEV1)) in predicting exercise impairment and
improvement in tolerance to effort after broncho-
dilators, especially in patients with more
advanced disease [3–5]. However, IC measure-
ments in isolation may provide insufficient
information about the actual elastic load during
exercise and, therefore, patients’ ability to sustain
exercise. CASANOVA et al. [6] have argued that IC
correction for the total lung capacity (TLC) would
provide a better characterisation of the volume
fraction available for inspiration than IC alone. In
fact, this so-called ‘‘inspiratory fraction’’ (IC/
TLC) has been found to constitute an important
prognostic factor in moderate-to-severe COPD.
Another prospective study [7] showed that air
trapping, expressed as increased residual volume
(RV)/TLC ratio, was a powerful predictor of
mortality in patients with COPD. To the current
authors’ knowledge, however, no previous study
has systematically evaluated the value of resting
IC/TLC in predicting maximal exercise tolerance
in this patient population.
Therefore, the primary objective of this study was
to investigate whether the inspiratory fraction
would be useful in predicting maximal exercise
capacity in COPD patients presenting with
increased static lung volumes at rest.
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METHODS
Subjects
The study population comprised 44 patients (33 males and 11
females) who had participated in an unpublished investigation
on the effects of neuromuscular electrical stimulation on
peripheral muscle function and structure. All subjects had a
clinical and functional diagnosis of COPD according to the
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
criteria (stage II524 and stage III520) [8], presenting with
FEV1/forced vital capacity (FVC) ratio ,0.7 and FEV1 ,80 but
.30% predicted. In addition, all patients were required to
present with increased static lung volumes at rest. Patients
were clinically stable for o4 weeks and were optimised in
terms of medical therapy, including short- and long-acting b2-
adrenergics, short- and long-acting anticholinergics and
inhaled steroids. Exclusion criteria were as follows: suspected
asthma; other systemic conditions that could contribute to
dyspnoea or exercise limitation, such as heart failure or
metabolic disorders; and resting arterial oxygen saturation
measured by pulse oximetry (Sp,O2; ,90%). Patients gave
informed consent and the study protocol was approved by a
Medical Ethics Committee.
Measurements
Anthropometry
Height was obtained to the nearest 0.5 cm with subjects
standing barefoot; body mass was measured with subjects in
light clothing and was established to the nearest 0.1 kg. Body
mass index (BMI; kg?m-2) was then calculated.
Pulmonary function
Spirometric tests were performed by using the CPF SystemTM
(Medical Graphics Corp., St Paul, MN, USA), with airflow
measured by a calibrated Pitot tube (PreVent PneumotachTM;
Medical Graphics Corp.). The subjects completed at least three
acceptable maximal forced and slow expiratory manoeuvres:
in order to assess exercise capacity under improved ventilatory
conditions, the patients were tested 20 min after the inhalation
of 400 mg of salbutamol via a metered-dose inhaler. FVC, FEV1
and IC were recorded in body temperature and pressure,
saturated conditions. Predicted values were those for the adult
Brazilian population [9].
The diffusing capacity of the lung for carbon monoxide (DL,CO)
was measured by the modified Krogh technique (single
breath); subjects performed two acceptable and reproducible
tests, with the results being within 10% or 3 mL?CO?min-1?
mmHg-1[10]. TLC (L) and RV (L) were obtained by constant-
volume, different-pressure body plethysmography and
expressed as a percentage of the predicted value according to
Brazilian standards [11]. Air trapping was defined as increased
RV/TLC and RV (.0.4 and .140% pred, respectively), TLC
values .120% pred were assumed to be indicative of lung
hyperinflation [12]. Arterial partial pressure for oxygen (Pa,O2)
and carbon dioxide (Pa,CO2) were measured (mmHg) in
anaerobic conditions.
Cardiopulmonary exercise test
Symptom-limited, ramp-incremental cycle ergometer exercise
tests were performed on a digital computer-based exercise
system (CardiO2 System; Medical Graphics Corp.) with
breath-by-breath analysis of metabolic, ventilatory and cardio-
vascular variables. The rate of power increment was indivi-
dually selected (usually 5–10 W?min-1) to provide an exercise
duration of .8 but ,12 min. The following data were recorded
as mean of 15 s: pulmonary oxygen uptake (V9O2; mL?min
-1);
minute ventilation (V9E; L?min-1); respiratory rate (RR) and
tidal volume (VT; L). Peak V9O2 was the highest value found at
exercise cessation; predicted values were in line with those of
NEDER et al. [13] for the adult Brazilian population. In the
present study, a peak V9O2 ,60% predicted was considered
indicative of a severely-reduced maximum aerobic capacity
[13]. Cardiac frequency (eC, bpm) was determined using the
R-R interval from a 12-lead online electrocardiogram. Subjects
were also asked to rate their ‘‘shortness of breath’’ at peak
exercise using the 0–10 Borg’s category-ratio scale [14].
Dyspnoea ratings were also corrected for the ongoing level of
total ventilatory stress (dyspnoea/V9E; Borg units?L-1?min-1).
Statistical analysis
Data are presented as mean and SD for normally distributed
variables (Kolmogorov–Smirnov), and median (range) other-
wise. Pearson’s correlation coefficient was used to assess the
level of association between continuous variables. Backward
stepwise multiple linear regression was performed to define
the independent predictors of peak V9O2 (% pred); resting
variables that were significantly related to peak V9O2 at the 10%
level (p,0.10) were considered for inclusion in the model. In
the regression analysis, however, only variables independently
related to peak V9O2 at the 5% level (p,0.05) were allowed to
remain in the final model. One-way ANOVA with post-hoc
Scheffe test was used to compare variables between the IC/
TLC groups. Receiver operating characteristic (ROC) curves
were obtained for selected resting physiological variables, in
order to predict a severely reduced maximal exercise capacity
(peak V9O2 ,60% pred). The areas under the ROC curves were
then compared according to DELONG et al. [15] for pairwise
differences. Sensitivity, specificity, positive and negative
predictive values, positive and negative likelihood ratios, and
accuracy were calculated for the cut-offs derived from the ROC
curves. The level of statistical significance was set at 5% for all
hypothesis tests (p,0.05).
RESULTS
Population characteristics
Resting and exercise characteristics are presented in table 1.
On average, patients had moderate-to-severe airflow obstruc-
tion with evidence of air trapping (n544) and lung hyper-
inflation (n518). Maximal exercise capacity (peak V9O2) was
below the lower limit of normal in 38 patients (86.3%) [12] and
16 subjects (36.3%) had a severe reduction in peak V9O2 (,60%
pred). Pulmonary-ventilatory limitation, as indicated by
increased V9Emax/maximal voluntary ventilation ratio
(.0.8), was found in all subjects; accordingly, dyspnoea was
the main exercise limiting symptom (table 1).
Relationship between resting parameters and maximal
exercise capacity
Maximal exercise capacity (peak V9O2, % pred) was signifi-
cantly related to a number of resting variables, including: IC/
TLC (r50.45, fig. 1), IC (r50.26), TLC (r50.38), RV (r50.48),
and FEV1 (r50.58). After multiple regression analysis, which
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considered all of these variables, only IC/TLC and FEV1
remained as independent predictors in the final model: peak
V9O2 (% pred)578.9 IC/TLC+26.1 FEV1 (% pred)+29.4 (p,0.01;
r250.334).
Lung function predictors of a severely reduced maximal
exercise capacity
As IC/TLC was an independent predictor of peak V9O2, this
relationship was examined more carefully. As shown in
figure 1, all but three patients with an IC/TLC f0.28 (group
I) had peak V9O2 values ,60% pred. However, only three
patients with an IC/TLC .0.28 (group II) had peak V’O2 values
,60% pred. In fact, there were several between–group
differences either at rest or during exercise (table 2). Group 1
patients had reduced BMI, worse lung function (airflow
obstruction, air trapping and lung hyperinflation) and, as
expected, lowest exercise capacity (p,0.05). Importantly, these
patients tended to present with reduced VT and increased
ventilation-corrected dyspnoea scores (table 2).
In order to compare the resting physiological variables in their
ability to predict a severely reduced peak V9O2, the area under
the ROC curves (AUC) for IC/TLC, IC (% pred) and FEV1 (%
pred), were compared. As shown in figure 2, IC/TLC had the
highest AUC (0.92); this value, however, showed a trend
towards statistical difference (p50.06) from IC only. Based on
this analysis, the cut-off points with the best sensitivity and
specificity for each functional variable were selected [14]: IC/
TLC50.28, IC575% pred, and FEV1550% pred. As shown in
table 3, an IC/TLC f0.28 was associated with the highest
specificity, positive predictive value, likelihood ratio for positive
and negative test results, and overall accuracy to predict a peak
V9O2 ,60% pred as compared with other variables.
DISCUSSION
The main original finding of the present study was that post-
bronchodilator IC/TLC ratio or inspiratory fraction, an index
of increased lung volumes, was an independent predictor of
maximal exercise capacity in patients with COPD. More
specifically, an IC/TLC f0.28 was likely to be related to a
severely reduced peak V9O2 (,60% pred); conversely, higher
IC/TLC values were commonly found in less disabled
patients. These data, in association with those previously
reported by CASANOVA et al. [6], which related to mortality,
indicate that the IC/TLC should be valued as a relevant index
of prognosis (f0.25) and disability (f0.28) in patients with
COPD.
Lung hyperinflation and exercise tolerance in COPD
It has long been recognised that the main pathophysiological
abnormality during dynamic exercise in COPD is expiratory
flow limitation; its consequences, however, are largely inspira-
tory and elastic as a result of DH [16]. Not surprisingly, several
TABLE 1 Patient characteristics at rest and maximal
exercise
Variables
Subjects n 44
Demographic/anthropometric
Sex M/F 33/11
Age yrs 64.1¡7.5
BMI kg?m-2 23.7¡4.0
Pulmonary function
FEV1 L 1.24¡0.49
FEV1 % pred 49.0¡16.4
FVC % pred 89.3¡21.8
FEV1/FVC 0.43¡0.09
TLC % pred 116.8¡16.4
RV % pred 205.2¡60.7
RV/TLC 0.55¡0.09
IC % pred 79.4¡17.2
IC/TLC 0.31¡0.07
DL,CO % pred 55.8¡18.9
Pa,O2 mmHg 66.5¡8.6
Pa,CO2 mmHg 41.3¡6.2
Maximal exercise
Peak V9O2 % pred 68.4¡16.5
Peak V9O2 mL?min
-1 998¡342
Power W 64¡29
V9E L?min-1 38.0¡13.5
V9E/MVV 0.83¡0.18
RR breaths?min-1 31.5¡5.1
VT L 1.20¡0.37
VT/resting IC 0.57¡0.15
eC % pred 85.9¡11.5)
Dyspnoea score 7 (5-10)
Dyspnoea/V9E 0.18¡0.10
Data are presented as mean¡SD or median (range), unless otherwise stated. M:
male; F: female; BMI: body mass index; FEV1: forced expiratory volume in one
second; % pred: % predicted; FVC: forced vital capacity; TLC: total lung
capacity; RV: residual volume; IC: inspiratory capacity; DL,CO: diffusing
capacity of the lung for carbon monoxide; Pa,O2: arterial oxygen tension;
Pa,CO2: carbon dioxide arterial tension; V9O2: oxygen uptake; V9E: minute
ventilation; MVV: maximal voluntary ventilation; RR: respiratory rate; VT: tidal
volume; eC : cardiac frequency. 1 mmHg50.133 kPa.
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FIGURE 1. Relationship between inspiratory capacity (IC)/total lung capacity
(TLC) ratio and maximal exercise capacity (peak oxygen uptake, V’O2) in a group of
44 patients with chronic obstructive pulmonary disease. % pred: percentage of
predicted. $: group 1 IC/TLC ,0.28; h: group 2 IC/TLC .0.28.
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authors have found that a decrease in the operating volumes
with bronchodilators, especially the end-expiratory lung
volume (EELV), are more likely to be related to clinically
meaningful changes in this patient population than traditional
measures of airflow [17–20]. Similarly, improvement in
exercise capacity and dyspnoea after lung-volume reduction
surgery was better associated with changes in EELV than with
FEV1 [21]. In the present study, measures of increased lung
volumes (IC, RV and IC/TLC) were all associated with
worsening maximum exercise capacity (table 2). Reduction in
exercise tolerance in patients with lower IC/TLC values (group
I) tended to be associated with lower VT and increased
ventilation-corrected dyspnoea at peak exercise (table 2). These
results seem to indicate that with exercise progression, patients
breathed at near-maximum (and less compliant) lung volumes,
although exercise IC values were not measured in the present
study (see Study limitations).
Physiological significance of IC/TLC
The theoretical advantage of IC/TLC over IC in isolation may
be related to the fact that a lower IC/TLC seems to better
reflect the deleterious combination of air trapping (increased
RV and RV/TLC) plus lung hyperinflation (increased TLC;
table 2). Therefore, two patients may present with similar IC
which is a widely different fraction of their maximal available
volume for lung expansion. In this context, the combination of
lower IC/TLC with increased TLC (i.e. a very high EELV) is
potentially more harmful than the isolated reduction in IC,
since the patient should breathe at his/her near-maximum
(and increased) TLC, with negative consequences on the elastic
work of breathing and dyspnoea.
A noticeable finding of the present study was the close
similarity between the IC/TLC cut-off for severe reduction in
peak V9O2 described herein, and that found by CASANOVA et al.
[6] for mortality in COPD. Although the exact nature of the
relationship between lung hyperinflation and mortality in
COPD is still elusive, it is interesting to note that a low IC/TLC
was related to reduced BMI, worse exercise capacity and,
marginally (p50.10), to decreased DL,CO (table 2), all indica-
tors of poor prognosis in COPD [22].
Clinical implications
Exercise capacity has been associated with disability, increased
usage of healthcare resources and even mortality in patients
with COPD [23]. Resting lung function measurements may be
useful in estimating the likelihood of a severe reduction in
TABLE 2 Resting and exercise parameters of patients according to inspiratory fraction (inspiratory capacity (IC)/ total lung
capacity (TLC))
Group I# Group II"
Subjects n 15 29
Demographic/anthropometric
Age yrs 65.2¡6.8 63.5¡7.9
BMI kg?m-2 21.0¡3.5 24.9¡3.6*
Pulmonary function
FEV1 % pred 38.4¡14.7 54.5¡14.5*
TLC % pred 125.4¡18.7 112.3¡13.4*
RV % pred 255.4¡64.3 179.3¡39.3*
RV/TLC 0.64¡0.07 0.51¡0.07*
IC % pred 65.0¡7.0 86.8¡16.2*
IC/TLC 0.23¡0.03 0.35¡0.05*
DL,CO % pred 47.8¡23.0 59.6¡15.8
Pa,O2 mmHg 65.2¡5.9 67.1¡9.6
Pa,CO2 mmHg 40.6¡5.0 41.7¡6.7
Maximal exercise
Peak V’O2 % pred 56.8¡16.6 74.4¡13.2*
Peak V’O2 mL?min
-1 784¡319 1109¡302*
Power W 48¡29 71¡26*
V9E L?min-1 29.9¡11.6 42.2¡12.6*
V9E/MVV 0.83¡0.18 0.83¡0.18
RR breaths?min-1 28¡3 32¡5*
VT L 1.04¡0.35 1.28¡0.35*
VT/resting IC 0.61¡0.20 0.55¡0.11
eC % pred 87.0¡9.5 85.5¡12.3
Dyspnoea/V9E 0.22¡0.14 0.17¡0.07
Data are presented as mean¡SD unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in one second; % pred: % predicted; RV: residual
volume; DL,CO: diffusing capacity of the lung for carbon monoxide; Pa,O2: arterial oxygen tension; Pa,CO2: carbon dioxide arterial tension; V9O2: oxygen uptake; V9E: minute
ventilation; MVV: maximal voluntary ventilation; RR: respiratory rate; VT: tidal volume; eC:cardiac frequency.*: p,0.05 group I versus group II. #: IC/TLC f0.28; ": IC/TLC
.0.28. 1 mmHg50.133 kPa.
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exercise tolerance [5]. The present results show that IC/TLC is
a readily available alternative for the prediction of severe
disability in COPD, with the advantage of also being
associated with mortality [6]. From a practical point of view,
if a COPD patient presents with an IC/TLC f0.28 (or f0.25),
he/she should be considered at increased risk of respiratory-
related disability and death.
Study limitations
A major limitation of the present study is related to the sample
size. Therefore, it cannot be ruled out that failure to
demonstrate a potential superiority of IC/TLC over other
physiological variables was due to an insufficient number of
patients with severe-to-very severe lung hyperinflation. In fact,
the present results should not be extrapolated for patients with
more advanced or milder disease. Another relevant limitation
was the lack of IC measurements during exercise, a physio-
logical outcome that has been shown to be superior to resting
IC in estimating exercise tolerance in patients with COPD [1]. It
could be speculated, however, that as patients with lower IC/
TLC had substantially increased operating lung volumes at
rest, as discussed above, they would tend to present with
lower exercise IC. However, recent studies using optoelec-
tronic plethysmography have found a variable behaviour of
exercise lung volumes in individual COPD patients, DH being
poorly related to static lung volumes [24, 25]. Future studies
are therefore warranted to evaluate how IC/TLC compares to
exercise IC in these patients. Also of importance is that,
submaximal exercise tolerance has been found to be more
closely related to patients functional capacity than peak
exercise; the accuracy of IC/TLC in identifying patients with
reduced tolerance to endurance exercise remains to be
investigated [26]. Moreover, it is currently unknown whether
pre-bronchodilator IC/TLC has any functional significance.
Finally, as mentioned, exercise intolerance is a multi-factorial
construct where pulmonary-ventilatory, cardiovascular and
peripheral factors interact in a complex way; IC/TLC (as any
lung function variable) should always be used in association
with other indices to estimate the degree of effort intolerance in
the individual patient.
In summary, the present study has shown, for the first time,
that the post-bronchodilator inspiratory fraction (inspiratory
capacity/total lung capacity) is an independent predictor of
severely reduced maximal exercise capacity in patients with
chronic obstructive pulmonary disease. Considering that this
variable has also been previously found to constitute a
significant prognostic index in chronic obstructive pulmonary
disease [6], the inspiratory fraction should be valued in the
functional evaluation of this patient population.
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